Ran Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ran Chen has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Jianzhong Du
East China University of Science and Technology
5 shared publications - Min Sun
East China University of Science and Technology
5 shared publications - Zhen Fan
Tongji University 4800 Caoan Road
5 shared publications - Jiaxi Xu
Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China
2 shared publications - Mingchen Lv
Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China
2 shared publications - Wei Hu
Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China
2 shared publications
Latest Publications
- 2 November 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (44) , 29998-30010
Intracellular Polymerization-Induced Self-Assembly of Peptide Nanosheets for Inflammatory Breast Cancer Therapy
Inflammatory breast cancer (IBC) is a highly aggressive breast cancer subtype characterized by diffuse, biologically invasive growth and poorly defined tissue boundaries, resulting in a high mortality rate even after multimodal treatment. Here, we report an intracellular polymerization-induced self-assembly (PISA) strategy that constructs mechanically active peptide nanosheets. Upon 365 nm UV irradiation, the photoinitiator Irgacure 2959 (I2959) initiates intracellular PISA of HisMAm in IBC cells. The corresponding nanosheets prepared in vitro exhibit a thickness of ∼30 nm and a wet-state apparent Young’s modulus of 8.02 ± 0.43 MPa. These nanosheets act through two coordinated materials-cell interactions: (i) increasing cellular viscosity and spatially associating with the actin cytoskeleton, suppressing cell migration and invasion; and (ii) accumulating in the endoplasmic reticulum and eliciting paraptosis-like cell death. In a subcutaneous IBC xenograft model, localized fiber-assisted light activation achieves 72.2% tumor growth inhibition without overt systemic toxicity. Overall, this work establishes intracellular PISA as a spatiotemporally controlled materials strategy for localized IBC treatment.
- 2 November 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (44) , 29998-30010
Intracellular Polymerization-Induced Self-Assembly of Peptide Nanosheets for Inflammatory Breast Cancer Therapy
Inflammatory breast cancer (IBC) is a highly aggressive breast cancer subtype characterized by diffuse, biologically invasive growth and poorly defined tissue boundaries, resulting in a high mortality rate even after multimodal treatment. Here, we report an intracellular polymerization-induced self-assembly (PISA) strategy that constructs mechanically active peptide nanosheets. Upon 365 nm UV irradiation, the photoinitiator Irgacure 2959 (I2959) initiates intracellular PISA of HisMAm in IBC cells. The corresponding nanosheets prepared in vitro exhibit a thickness of ∼30 nm and a wet-state apparent Young’s modulus of 8.02 ± 0.43 MPa. These nanosheets act through two coordinated materials-cell interactions: (i) increasing cellular viscosity and spatially associating with the actin cytoskeleton, suppressing cell migration and invasion; and (ii) accumulating in the endoplasmic reticulum and eliciting paraptosis-like cell death. In a subcutaneous IBC xenograft model, localized fiber-assisted light activation achieves 72.2% tumor growth inhibition without overt systemic toxicity. Overall, this work establishes intracellular PISA as a spatiotemporally controlled materials strategy for localized IBC treatment.
- 14 August 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (34) , 48017-48028
Ultrasound-Driven Cu-Nanobots for Tumor Deep Penetration and Induction of Cuproptosis in Prostate Cancer Therapy
Cuproptosis has attracted considerable attention in cancer therapy due to its unique ability to circumvent drug resistance, while the in vivo application is hindered by systemic toxicity, rapid clearance, and limited tumor tissue penetration. Widely recognized for its noninvasive application, ultrasound has emerged as a promising method for enhancing drug tumor penetration. In this study, we developed cuproptosis-oriented Nanobots to achieve deep penetration into prostate tumors under ultrasound irradiation. Asymmetric Cu-Nanobots (∼200 nm) were prepared by ultrasound polymerization using hexachlorocyclotriphosphonitrile (HCCP), 4,4'-sulfonyldiphenol (BPS), and tannic acid (TA) as raw materials, which can efficiently load Cu2+ and trigger Cu2+ release at acidic tumor microenvironments. Under ultrasound stimulation, Cu-Nanobots showed obvious directional motion with a velocity of 19.49 μm/s continuously. In vitro cell experiments confirmed that Cu-Nanobots can significantly promote the oligomerization of dihydrolipoamide acetyltransferase (DLAT), downregulate iron-sulfur cluster proteins such as ferredoxin 1 (FDX1) and lipoic acid synthase (LIAS), and induce cuproptosis in human prostate cancer cells. In addition, Cu-Nanobots can effectively penetrate into the deep area of solid tumors in an animal model with a satisfactory tumor inhibition rate of ∼75.75% under sonication. Overall, these ultrasound-driven cuproptosis-oriented Cu-Nanobots provide optimal insights into effective tumor deep penetration and cuproptosis-based treatment.
- 14 August 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 17 (34) , 48017-48028
Ultrasound-Driven Cu-Nanobots for Tumor Deep Penetration and Induction of Cuproptosis in Prostate Cancer Therapy
Cuproptosis has attracted considerable attention in cancer therapy due to its unique ability to circumvent drug resistance, while the in vivo application is hindered by systemic toxicity, rapid clearance, and limited tumor tissue penetration. Widely recognized for its noninvasive application, ultrasound has emerged as a promising method for enhancing drug tumor penetration. In this study, we developed cuproptosis-oriented Nanobots to achieve deep penetration into prostate tumors under ultrasound irradiation. Asymmetric Cu-Nanobots (∼200 nm) were prepared by ultrasound polymerization using hexachlorocyclotriphosphonitrile (HCCP), 4,4'-sulfonyldiphenol (BPS), and tannic acid (TA) as raw materials, which can efficiently load Cu2+ and trigger Cu2+ release at acidic tumor microenvironments. Under ultrasound stimulation, Cu-Nanobots showed obvious directional motion with a velocity of 19.49 μm/s continuously. In vitro cell experiments confirmed that Cu-Nanobots can significantly promote the oligomerization of dihydrolipoamide acetyltransferase (DLAT), downregulate iron-sulfur cluster proteins such as ferredoxin 1 (FDX1) and lipoic acid synthase (LIAS), and induce cuproptosis in human prostate cancer cells. In addition, Cu-Nanobots can effectively penetrate into the deep area of solid tumors in an animal model with a satisfactory tumor inhibition rate of ∼75.75% under sonication. Overall, these ultrasound-driven cuproptosis-oriented Cu-Nanobots provide optimal insights into effective tumor deep penetration and cuproptosis-based treatment.
- Open Access
- 30 April 2025
- Published by American Chemical Society (ACS) in Polymer Science & Technology
- Vol. 1 (7) , 584-606
Recent Advances and Future Prospects in Biological-Membrane-Targeted Polymers
Membrane structures play a crucial role in biological systems, not only serving as a barrier between cells/organelles and the external microenvironment but also playing key roles in important biological processes such as material exchange, signal transduction, and cell proliferation. With the advancement of related research, membrane-targeting strategies have gradually been a focus in modern cancer therapy and antimicrobial studies. Polymer materials show great promise in membrane-targeted therapy due to their excellent biocompatibility, tunability, and functionalization potential. Presented in this review are design strategies for polymer materials targeting cell and organelle membranes. Initially, we introduce the functions and characteristics of tumor cell membranes, organelle membranes, and bacterial cell walls, whose unique physicochemical properties offer potential pathways for targeted therapy. Next, we focus on various strategies for designing polymer materials with membrane targeting features. For instance, by adjusting the charge density and hydrophilicity/hydrophobicity of polymer chains, cationic polymers (e.g., polyethylenimine and polyamidoamine dendrimers) can leverage electrostatic interactions to disrupt the integrity of the cell membrane, leading to pore formation or structural disruption, which facilitates efficient cytosolic delivery. Thirdly, functionalized polymers can specifically recognize target membranes, thereby reducing side effects. Studies have demonstrated that modified polymers not only facilitate targeted delivery to specific organs but also enhance cellular uptake efficiency by up to 10 times. Finally, we discuss existing challenges and future directions of polymer materials for membrane-targeted therapeutics, aiming to provide insight for advancing membrane-targeted polymers and improving existing treatment strategies for more precise disease management.
- 30 April 2025
- Published by American Chemical Society (ACS) in Polymer Science & Technology
- Vol. 1 (7) , 584-606
Open AccessRecent Advances and Future Prospects in Biological-Membrane-Targeted Polymers
Membrane structures play a crucial role in biological systems, not only serving as a barrier between cells/organelles and the external microenvironment but also playing key roles in important biological processes such as material exchange, signal transduction, and cell proliferation. With the advancement of related research, membrane-targeting strategies have gradually been a focus in modern cancer therapy and antimicrobial studies. Polymer materials show great promise in membrane-targeted therapy due to their excellent biocompatibility, tunability, and functionalization potential. Presented in this review are design strategies for polymer materials targeting cell and organelle membranes. Initially, we introduce the functions and characteristics of tumor cell membranes, organelle membranes, and bacterial cell walls, whose unique physicochemical properties offer potential pathways for targeted therapy. Next, we focus on various strategies for designing polymer materials with membrane targeting features. For instance, by adjusting the charge density and hydrophilicity/hydrophobicity of polymer chains, cationic polymers (e.g., polyethylenimine and polyamidoamine dendrimers) can leverage electrostatic interactions to disrupt the integrity of the cell membrane, leading to pore formation or structural disruption, which facilitates efficient cytosolic delivery. Thirdly, functionalized polymers can specifically recognize target membranes, thereby reducing side effects. Studies have demonstrated that modified polymers not only facilitate targeted delivery to specific organs but also enhance cellular uptake efficiency by up to 10 times. Finally, we discuss existing challenges and future directions of polymer materials for membrane-targeted therapeutics, aiming to provide insight for advancing membrane-targeted polymers and improving existing treatment strategies for more precise disease management.
- Open Access
- 1 November 2024
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 4 (11) , 4162-4186
Precise Regulations at the Subcellular Level through Intracellular Polymerization, Assembly, and Transformation
A living cell is an intricate machine that creates subregions to operate cell functions effectively. Subcellular dysfunction has been identified as a potential druggable target for successful drug design and therapy. The treatments based on intracellular polymerization, self-assembly, or transformation offer various advantages, including enhanced blood circulation of monomers, long-term drug delivery pharmacokinetics, low drug resistance, and the ability to target deep tissues and organelles. In this review, we discuss the latest developments of intracellular synthesis applied to precisely control cellular functions. First, we discuss the design and applications of endogenous and exogenous stimuli-triggered intracellular polymerization, self-assembly, and dynamic morphology transformation of biomolecules at the subcellular level. Second, we highlight the benefits of these strategies applied in cancer diagnosis and treatment and modulating cellular states or cell metabolism of living systems. Finally, we conclude the recent progress in this field, discuss future perspectives, analyze the challenges of the intracellular functional reactions for regulation, and find future opportunities.
- 1 November 2024
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 4 (11) , 4162-4186
Open AccessPrecise Regulations at the Subcellular Level through Intracellular Polymerization, Assembly, and Transformation
A living cell is an intricate machine that creates subregions to operate cell functions effectively. Subcellular dysfunction has been identified as a potential druggable target for successful drug design and therapy. The treatments based on intracellular polymerization, self-assembly, or transformation offer various advantages, including enhanced blood circulation of monomers, long-term drug delivery pharmacokinetics, low drug resistance, and the ability to target deep tissues and organelles. In this review, we discuss the latest developments of intracellular synthesis applied to precisely control cellular functions. First, we discuss the design and applications of endogenous and exogenous stimuli-triggered intracellular polymerization, self-assembly, and dynamic morphology transformation of biomolecules at the subcellular level. Second, we highlight the benefits of these strategies applied in cancer diagnosis and treatment and modulating cellular states or cell metabolism of living systems. Finally, we conclude the recent progress in this field, discuss future perspectives, analyze the challenges of the intracellular functional reactions for regulation, and find future opportunities.
- 17 October 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (43) , 57963-57971
Ultrasound-Responsive Hydrogel Incorporated with TGF-β Mimetic Peptides for Endometrium Recovery to Restore Fertility
Unavoidable damage to the basal layer of the endometrium has a huge negative impact on a woman's reproductive health and menstrual cycle. However, it is difficult for medicine to penetrate a series of biological barriers toward the basal layer in the deeper area of the endometrium. To meet this challenge, we developed an ultrasound-responsive hydrogel incorporated with a transforming growth factor-beta (TGF-β) mimetic peptide to enhance pregnancy outcomes by restoring the function of a wounded endometrium due to its deep-tissue-penetration capability. In vitro studies revealed that the TGF-β-mimetic-peptide-loaded hydrogel could achieve 64.35% of cell migration under ultrasound stimulation even in phosphate-buffered saline of pH 6.0. Upon in situ sonication at the uterus, carboxymethyl chitosan can be released from degraded hydrogel to open tight junctions with reduced interstitial pressure by ultrasound to promote deep penetration. Rat studies revealed that the penetration capability of TGF-β-mimetic-peptide-loaded hydrogel with sonication was 1.6 times higher than that of the control group. Besides the rat uterine model, ex vivo human uterine tissue was also collected and imaged, demonstrating up to ∼700 μm of tissue penetration depth. In addition, compared to control groups, effective uterus recovery without intrauterine stenosis and endometrial cavity fluid was observed from rats with severe uterine injury treated by TGF-β-mimetic-peptide-loaded hydrogel. In addition, fertility restoration in the endometrial injury model was observed after treatment with such an ultrasound-responsive hydrogel incorporated with TGF-β mimetic peptides. Overall, this work provides an effective approach to treating endometrial injury for enhanced pregnancy outcomes.
- 17 October 2024
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 16 (43) , 57963-57971
Ultrasound-Responsive Hydrogel Incorporated with TGF-β Mimetic Peptides for Endometrium Recovery to Restore Fertility
Unavoidable damage to the basal layer of the endometrium has a huge negative impact on a woman's reproductive health and menstrual cycle. However, it is difficult for medicine to penetrate a series of biological barriers toward the basal layer in the deeper area of the endometrium. To meet this challenge, we developed an ultrasound-responsive hydrogel incorporated with a transforming growth factor-beta (TGF-β) mimetic peptide to enhance pregnancy outcomes by restoring the function of a wounded endometrium due to its deep-tissue-penetration capability. In vitro studies revealed that the TGF-β-mimetic-peptide-loaded hydrogel could achieve 64.35% of cell migration under ultrasound stimulation even in phosphate-buffered saline of pH 6.0. Upon in situ sonication at the uterus, carboxymethyl chitosan can be released from degraded hydrogel to open tight junctions with reduced interstitial pressure by ultrasound to promote deep penetration. Rat studies revealed that the penetration capability of TGF-β-mimetic-peptide-loaded hydrogel with sonication was 1.6 times higher than that of the control group. Besides the rat uterine model, ex vivo human uterine tissue was also collected and imaged, demonstrating up to ∼700 μm of tissue penetration depth. In addition, compared to control groups, effective uterus recovery without intrauterine stenosis and endometrial cavity fluid was observed from rats with severe uterine injury treated by TGF-β-mimetic-peptide-loaded hydrogel. In addition, fertility restoration in the endometrial injury model was observed after treatment with such an ultrasound-responsive hydrogel incorporated with TGF-β mimetic peptides. Overall, this work provides an effective approach to treating endometrial injury for enhanced pregnancy outcomes.